-

05:13:52 PM

NSTG Stock News

NSTG - Nanostring Technologies Inc

09/19/23 1:08 PM

Nasdaq : TXG, NSTG

10x Wins Injunction From Unified Patent Court Banning Sales of NanoString's CosMx Products in Europe

10 x Genomics, Inc., a leader in single cell and spatial biology, announced today that the European Unified Patent Court issued a preliminary injunction against NanoString Technologies, Inc. for infringing European Patent 4 108 782 B1. The injunction on the EP 782 patent...

RHEA-AI

negative

09/19/23 11:54 AM

Nasdaq : NSTG

high short

NanoString Comments on Unified Patent Court Order

NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, commented on today’ s order from the European Unified Patent Court granting a preliminary injunction effective immediately in 17 Member States of the European Union against NanoString’ s CosMx™ Spatial Molecular Imager products for RNA...

RHEA-AI

neutral

09/14/23 6:00 AM

Nasdaq : NSTG

conferenceshigh short

NanoString to Host Virtual Spatial Genomics Summit September 19

NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced it will host its fifth annual Spatial Genomics Summit, September 19 th. The two-hour virtual event will showcase advances in the rapidly expanding field of spatial biology with talks from scientific leaders harnessing the power and...

RHEA-AI

very positive

09/13/23 6:00 AM

Nasdaq : NSTG

high short

NanoString Launches the Most Comprehensive Spatial Proteomics Panel Ever Offered

NanoString Technologies, a leading provider of life science tools for discovery and translational research, announced today the launch of the latest assay for the GeoMx ® Digital Spatial Profiler. The GeoMx IO Proteome Atlas is the industry’ s most comprehensive spatial proteomics assay, enabling spatial profiling of more than 500 immuno-oncology...

RHEA-AI

very positive

09/07/23 6:00 AM

Nasdaq : NSTG

partnershiphigh short

NanoString Expands Partnerships with Contract Research Organizations Making Spatial Molecular Imaging Tools Widely Available to Global BioPharma Researchers

Macrogen, Propath UK, and Sirona Dx offer global biopharma customers new access to CosMx™ SMI technology for translational drug development. Portland, Oregon- based Sirona Dx, one of the earliest CosMx SMI adopters, has acquired multiple systems in response to strong demand from clients.“ Platform selection is one of the most important decisions to make when...

RHEA-AI

very positive

09/05/23 6:00 AM

Nasdaq : NSTG

conferenceshigh short

NanoString to Webcast Presentations from Upcoming Healthcare Conferences

NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast presentations from two upcoming healthcare conferences. Morgan Stanley 21 st Annual Global Heathcare Conference Tuesday, September 12th Brad Gray, NanoString’ s chief...

RHEA-AI

neutral

08/28/23 5:53 AM

Nasdaq : NSTG

managementhigh short

NanoString Appoints Todd Garland as Chief Commercial Officer

NanoString Technologies, Inc., a provider of life science tools for discovery and translational research, today announced that Todd Garland has been appointed Chief Commercial Officer, effective August 28, 2023.. This press release features multimedia. Garland spent 6 years at BD Biosciences, a $1.2 billion life sciences tools company, as Vice President and...

RHEA-AI

very positive

08/21/23 6:00 AM

Nasdaq : NSTG

high short

NanoString Platforms Advance Groundbreaking Studies of Immune Response in Pig-to-Human Organ Transplants

NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced today that a team of globally renowned researchers utilized two NanoString platforms, the nCounter ® Analysis System and GeoMx ® Digital Spatial Profiler, to decode the immune response following the transplantation of...

RHEA-AI

neutral

08/08/23 5:00 AM

Nasdaq : NSTG

conferenceshigh short

NanoString to Webcast Presentations from Upcoming Healthcare Conferences

NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast presentations from two upcoming healthcare conferences. 43rd Annual Canaccord Global Growth Conference Wednesday, August 9th Tom Bailey, NanoString’ s chief financial officer,...

RHEA-AI

neutral

08/03/23 4:00 PM

Nasdaq : NSTG

earningshigh short

NanoString Technologies Releases Operating Results for Second Quarter of 2023

Total revenue of $44.2 million Spatial biology revenue of $23.3 million nCounter ® revenue, inclusive of all service and other revenue, of $20.9 million Cash, cash equivalents and short-term investments balance of $117.6 million as of June 30, 2023. Accelerated CosMx shipments during Q2, resulting in Q2 spatial biology instrument revenue growth of 188%...

RHEA-AI

negative

1 2 3 4 5 6 7 8 9 10 Next

NSTG Data

IndustryBiological Product (except Diagnostic) Manufacturing
Websitehttps://www.nanostring.com
Security nameNanostring Technologies Inc
SectorManufacturing
Tags
- Health Technology
- Biotechnology
- Manufacturing
- Biological Product (except Diagnostic) Manufacturing
CountryUS

About Nanostring Technologies Inc

nanostring technologies (nasdaq: nstg) is a publicly held provider of life science tools for translational research and molecular diagnostics. the company's technology enables a wide variety of basic research, translational medicine and in vitro diagnostics applications. nanostring technologies provides life science tools for translational research and molecular diagnostic products. the company's ncounter® analysis system, which has been employed in basic and translational research since it was first introduced in 2008 and cited in more than 300 peer-reviewed publications, has also now been applied to diagnostic use as the ncounter dx analysis system. the company's technology offers a cost-effective way to easily profile the expression of hundreds of genes, mirnas, or copy number variations, simultaneously with high sensitivity and precision. the company's technology enables a wide variety of basic research and translational medicine applications, including biomarker discovery and vali